Table 1.
Summary of Baseline Characteristics for Randomized Participants.
| Characteristic | MDI + RT-CGM group, N = 5 | AHCL group, N = 8 | ||
|---|---|---|---|---|
| N | Value | N | Value | |
| Age (years) | ||||
| Mean | 5 | 36.2 ± 15.8 | 8 | 45.4 ± 13.3 |
| Range | 5 | 18-59 | 8 | 18-61 |
| Male, n (%) | 5 | 2 (40.0) | 8 | 5 (62.5) |
| Duration of T1D, years | 5 | 13.4 ± 8.6 | 8 | 17.4 ± 10.4 |
| Height, cm | 5 | 170.8 ± 11.3 | 7 | 174.1 ± 8.6 |
| Weight, kg | 5 | 78.8 ± 24.4 | 7 | 79.8 ± 26.2 |
| BMI, kg/m2 | 5 | 26.6 ± 5.6 | 7 | 26.1 ± 7.6 |
| HbA1c, % | 5 | 9.5 ± 0.6 | 8 | 8.9 0 ± 0.5 |
| HbA1c, mmol/mol | 5 | 79.9 ± 6.7 | 8 | 73.8 ± 5.0 |
| Insulin total daily dose, units | 5 | 79.2 ± 47.1 | 8 | 52.8 ± 29.1 |
| Sensor readings last month, % | 5 | 90.2 ± 10.1 | 8 | 93.1 ± 6.8 |
Values are mean ± SD unless otherwise stated.
Abbreviations: AHCL, advanced hybrid closed loop; BMI, body mass index; HbA1c, glycated hemoglobin; MDI + RT-CGM, multiple daily injections of insulin + real-time continuous glucose monitoring; T1D, type 1 diabetes.